About Transgene

Company Description

Transgene is a publicly traded French biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer.

A pioneer in viral vectors engineering, we have one ambition: design innovative treatments in the fight against cancer.

Our approach uses the mechanisms of the immune response to enable the patientโ€™s body to fight against disease.

Year founded

1979

Served area

Worldwide

Headcount

160

Headquarters

Parc d'Innovation 400 Boulevard Gonthier d Andernach, 67405 Illkirch Graffenstaden Cedex โ€“ France

Shareholder information

Shares outstanding

100,204,071

IPO

Jan. 12, 2001

Stock exchange(s)

Euronext Paris

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.